Back

The minor spliceosome is a master immune regulator

Johnson, M. B.; Russ-Silsby, J.; Blair, P. A.; Govier, M.; Bonfield, G.; Domingo-Vila, C.; EXE-T1D consortium, ; ATAC clinical consortium, ; Wakeling, M. N.; Oram, R. A.; Flanagan, S. E.; Tree, T. I.; Patel, K. A.; Hattersley, A. T.; De Franco, E.

2025-09-14 genetic and genomic medicine
10.1101/2025.09.12.25335567 medRxiv
Show abstract

Pathogenic variants in non-coding genes are emerging as critical contributors to human rare diseases. We identified 19 individuals with early-onset diabetes (diagnosed <5 years) and additional clinical features who had biallelic pathogenic variants in the novel disease gene RNU6ATAC (n=7) or in RNU4ATAC (n=12). Both genes encode non-coding components of the minor spliceosome, a protein-RNA complex mediating splicing of [~]700 genes containing U12/minor-type introns. RNA-seq of whole blood from six patients showed aberrant splicing of minor intron-containing genes in individuals with RNU6ATAC (n=3) or RNU4ATAC (n=3) variants. 50% of patients tested were islet-autoantibody positive, and 12/19 had additional immune features of immune dysregulation. Analysis of patients transcriptomic, methylation and immune data revealed impaired B cell development and maturation. Biallelic disease-causing variants in RNU6ATAC and RNU4ATAC therefore cause syndromic early-onset autoimmune diabetes and immune dysregulation, highlighting the critical role of the minor spliceosome as a master regulator of the human immune system.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.